Heß, G., & Witzens-Harig, M. (2015). Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma. Leukemia, 29(8), . https://doi.org/10.1038/leu.2015.60
Chicago-Zitierstil (17. Ausg.)Heß, Georg, und Mathias Witzens-Harig. "Safety and Efficacy of Temsirolimus in Combination with Bendamustine and Rituximab in Relapsed Mantle Cell and Follicular Lymphoma." Leukemia 29, no. 8 (2015). https://doi.org/10.1038/leu.2015.60.
MLA-Zitierstil (9. Ausg.)Heß, Georg, und Mathias Witzens-Harig. "Safety and Efficacy of Temsirolimus in Combination with Bendamustine and Rituximab in Relapsed Mantle Cell and Follicular Lymphoma." Leukemia, vol. 29, no. 8, 2015, https://doi.org/10.1038/leu.2015.60.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.